Plasma Biotal India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 30.45%
(FY 2023)
- Profit 88.98%
(FY 2023)
- Ebitda 157.53%
(FY 2023)
- Net Worth -1.98%
(FY 2023)
- Total Assets 1.02%
(FY 2023)
About Plasma Biotal India
The Corporate was formerly known as I Maintain Medrec Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suchitra Jitendra, Jitendra Hegde, Duncan Anderson, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2011PTC214403
- Company No.
214403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Plasma Biotal India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchitra Jitendra  | Director | 04-Mar-2011 | Current |
| Jitendra Hegde | Director | 04-Mar-2011 | Current |
Duncan Anderson  | Director | 12-Dec-2016 | Current |
| Paul Steverson | Director | 12-Dec-2016 | Current |
Financial Performance of Plasma Biotal India.
Plasma Biotal India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.45% increase. The company also saw a substantial improvement in profitability, with a 88.98% increase in profit. The company's net worth dipped by a decrease of 1.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plasma Biotal India?
In 2023, Plasma Biotal India had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Biomedicon Services (India) Private LimitedActive 19 years 2 monthsSuchitra Jitendra and Jitendra Hegde are mutual person
Biomedicon Care Private LimitedActive 29 years 10 daysSuchitra Jitendra and Jitendra Hegde are mutual person
Athaayu Multispeciality Hospitals LimitedActive 19 years 9 monthsSuchitra Jitendra and Jitendra Hegde are mutual person
Biorad Medisys Private LimitedActive 24 years 9 monthsSuchitra Jitendra and Jitendra Hegde are mutual person
Indovasive Private LimitedActive 2 years 2 monthsSuchitra Jitendra and Jitendra Hegde are mutual person
- Neurovasive Private LimitedActive 2 years 2 months
Suchitra Jitendra and Jitendra Hegde are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plasma Biotal India?
Unlock and access historical data on people associated with Plasma Biotal India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plasma Biotal India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasma Biotal India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
